VLP Therapeutics Japan, LLC

VLP Therapeutics Japan, LLC (VLPT Japan), founded in 2020 by Dr. Wataru Akahata and headquartered in Tokyo, Japan, is a wholly-owned subsidiary of US-based VLP Therapeutics, Inc. VLPT Japan is currently engaged in research and development of novel coronavirus disease (COVID-19) vaccines using self-amplifying (replicon) RNA technology proprietary to VLPT, with support from the Japan Agency for Medical Research and Development (AMED).